Can Chlorpheniramine Maleate and Dextromethorphan Be Used in the Second Trimester?
Yes, both chlorpheniramine maleate and dextromethorphan can be used during the second trimester of pregnancy with reassuring safety data.
Chlorpheniramine Maleate Safety Profile
Chlorpheniramine is considered one of the safest antihistamines during pregnancy, including the second trimester. Guidelines specifically identify chlorpheniramine as the preferred first-generation antihistamine when treatment is necessary during pregnancy due to its long safety record 1, 2.
The 2008 rhinitis management guidelines state that both first-generation and second-generation antihistamines have excellent safety records and do not show significant increases in congenital malformations when used during the first trimester 1. Since organogenesis occurs primarily in the first trimester 1, the safety profile is even more favorable in the second trimester when organ formation is complete.
Key evidence supporting chlorpheniramine use:
- Chlorpheniramine is often chosen by U.K. clinicians when antihistamine therapy is necessary because of its long safety record 2
- Large observational studies covering over 1.2 million pregnancies found no statistically significant associations between antihistamine use and major congenital malformations, spontaneous abortions, or premature births 3
- The FDA drug label advises consulting a health professional if pregnant, but does not contraindicate use 4
Dextromethorphan Safety Profile
Dextromethorphan has been extensively studied and demonstrates no increased teratogenic risk in human pregnancy. A controlled study of 184 pregnant women who used dextromethorphan found that among 128 women who used it during the first trimester, there were only 2.3% major malformations—within the expected baseline rate of 1-3% 5. The study concluded that dextromethorphan use during pregnancy does not increase rates of major malformations above baseline 5.
Additional supporting evidence:
- Mean birth weight (3,381g) was comparable to controls (3,446g) 5
- No increase in spontaneous abortion rates compared to matched controls 5
- The drug has been used safely since it became available, with accumulating human safety data 6
Clinical Recommendation for Second Trimester Use
Both medications can be used together in the second trimester when clinically indicated. The combination is commonly found in over-the-counter cough and cold preparations and has been used extensively without documented harm 7, 8.
Important Considerations:
- The most critical period for medication-related congenital malformations is the first trimester during organogenesis 1. By the second trimester, this risk window has passed
- Use the lowest effective dose for the shortest duration necessary to control symptoms
- Chlorpheniramine may cause sedation, which should be discussed with the patient regarding daily activities
- Both medications have been used for decades with extensive post-marketing surveillance showing favorable safety profiles
Common Pitfall to Avoid:
Do not unnecessarily withhold these medications in the second trimester based on overly cautious product labeling. The FDA drug label's generic warning to "ask a health professional before use" 4 reflects medicolegal caution rather than evidence of harm. The accumulated human data strongly supports safety, particularly after the first trimester when organogenesis is complete.
The evidence clearly supports using both chlorpheniramine maleate and dextromethorphan during the second trimester when symptomatic relief is needed 1, 5, 6.